Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is H and Author is Hur, Jin  [Clear All Filters]
Journal Article
Kang J, Hur J, Kang J-A, Yun J-Y, Choi J-I, Ko SBum, Lee C-S, Lee J, Han J-K, Kim HKyung, et al. Activated platelet supernatant can augment the angiogenic potential of human peripheral blood stem cells mobilized from bone marrow by G-CSF. J Mol Cell Cardiol. 2014.
Lee SHun, Lee JHee, Yoo SYoung, Hur J, Kim H-S, Kwon SMo. Hypoxia Inhibits Cellular Senescence to Restore the Therapeutic Potential of Old Human Endothelial Progenitor Cells via the Hypoxia-Inducible Factor-1α-TWIST-p21 Axis. Arterioscler Thromb Vasc Biol. 2013.
Park H, Kim D, Cho B, Byun J, Kim YSook, Ahn Y, Hur J, Oh Y-K, Kim J. In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction. Biomaterials. 2021;281:121327.
Kang HJin, Kang WSeok, Hong MHwa, Choe N, Kook H, Jeong HChang, Kang J, Hur J, Jeong MHo, Kim YSook, et al. Involvement of miR-34c in high glucose-insulted mesenchymal stem cells leads to inefficient therapeutic effect on myocardial infarction. Cell Signal. 2015.
Hur J, Baek SHee, Kim H-S. KAI1(CD82)-DARC(CD234) Axis in the Stem Cell Niche. Cell Cycle. 2016.
Yang H-M, Kim J-Y, Cho H-J, Lee J-E, Jin S, Hur J, Kwon Y-W, Seong M-W, Choi E-K, Lee H-Y, et al. NFATc1+CD31+CD45- circulating multipotent stem cells derived from human endocardium and their therapeutic potential. Biomaterials. 2019;232:119674.
Kang J, Hur J, Kang J-A, Lee HSeung, Jung H, Choi J-I, Lee H, Kim YSook, Ahn Y, Kim H-S. Priming mobilized peripheral blood mononuclear cells with the 'Activated Platelet Supernatant' enhances the efficacy of cell therapy for myocardial infarction of rats. Cardiovasc Ther. 2016.
Ha M, Kim J, Park SMin, Hong CMi, Han M-E, Song P, Kang C-D, Lee D, Kim YHak, Hur J, et al. Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma. Genet Test Mol Biomarkers. 2020.